Kansas City, Kan- Dr. Sean Kumer and his colleagues discussed a pilot study at the University of Kansas Medical Center on creatine's potential benefits for Alzheimer's patients. The study, involving 20 participants with mild to moderate Alzheimer's, found a 10.6% increase in brain creatine levels and improvements in working memory and executive function.  

Dr. Sean Kumer, Chief Medical Officer, The University of Kansas Health System

• Expresses appreciation to his colleagues that this type of research is taking place at The University of Kansas Health System.
• Encourages people to discuss creatine or any supplement with their doctor.

Dr. Matthew Taylor, Associate Professor of Dietetics and Nutrition, The University of Kansas Medical Center

• Dr. Matthew Taylor discusses his lab's focus on brain energy metabolism and Alzheimer's disease.
• The study is a single-arm pilot trial with no control group, focusing on the effects of creatine on brain energy metabolism and involved 20 patients.
• The study with patients with mild to moderate Alzheimer's, found a 10.6% increase in brain creatine levels and improvements in working memory and executive function.

Dr. Scott Mullen, Orthopedic Surgery and Sports Medicine, The University of Kansas Health System

• Dr. Scott Mullen explains the role of creatine in muscle energy supply and his personal experience with creatine.
• He suggests creatine as a safe supplement for maintaining muscle mass, especially in older adults.

Dr. Jeff Burns, neurologist, Co-Director University of Kansas Alzheimer's Disease Research Center

• Dr. Jeff Burns discusses the connection between Alzheimer's disease and brain energy metabolism.
• He emphasizes the need for larger, placebo-controlled trials to confirm the results.